These new generation fast acting treatments will replace old school depression drugs. The problem with ketamine is some side effects and the treatment losing efficacy over time. Well, the worse is the intravenous delivery mechanism.
An oral drug will blow the industry away. One more thing we learned is J&J is trying to do a nasal ketamine therapy. You would still have to go to doctors and have it administered.
VTGN future is very bright. Stock price wise, I think we have seen the bottom and the upside is 10 to 30 times or more.
News 
Market Data 
Discover 
